| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 734949 | 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide | 0.011265111688021 | 0.27046817 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.011265111688021 | 0.48310047 |
| NSC 749600 | Null | 0.011265111688021 | 0.44123082 |
| NSC 751042 | Null | 0.011265111688021 | 0.2195971 |
| NSC 762901 | trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide | 0.011265111688021 | 0.15169638 |
| NSC 704080 | Null | 0.011544784012433 | -0.018757201 |
| NSC 722508 | 2-(4-ethylpiperazinyl)3-p-methoxybenzoyl quinoxaline | 0.011544784012433 | 0.15140263 |
| NSC 727972 | 3-chloro-1-(4-chlorobenzyl)-4-(3-trifluoromethylanilino)-2,5 -dihydro-1H-2,5-pyrroledione | 0.011544784012433 | 0.1838678 |
| NSC 731104 | Null | 0.011544784012433 | 0.2529918 |
| NSC 744683 | Null | 0.011544784012433 | 0.36194593 |